scholarly journals P0729 / #2119: HYPONATREMIC HYPERTENSIVE SYNDROME (HHS) IN AN 8-MONTH-OLD CHILD PRESENTING AS STATUS EPILEPTICUS AND HYPERTENSIVE CRISIS IN PEDIATRIC INTENSIVE CARE UNIT (PICU): A CASE REPORT

2021 ◽  
Vol 22 (Supplement 1 3S) ◽  
pp. 351-351
Author(s):  
F.S. Bouchama ◽  
K. Elhalimi ◽  
R. Taibi ◽  
M.A. Negadi
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Case Report ◽  
Status Epilepticus ◽  
Pediatric Intensive Care Unit ◽  
Hypertensive Crisis ◽  
Pediatric Intensive Care ◽  
Hyponatremic Hypertensive Syndrome

scholarly journals Non-Convulsive Status Epilepticus at Pediatric Intensive Care Unit: A Single Center Experience

2021 ◽  
pp. 1-6
Author(s):  
Omnia F El-Rashiedy ◽  
◽  
Hanan M Ibrahim ◽  
Rania H Shatla ◽  
◽  
...  
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Status Epilepticus ◽  
Pediatric Intensive Care Unit ◽  
Pediatric Intensive Care ◽  
Convulsive Status Epilepticus ◽  
Eeg Monitoring ◽  
Single Center Experience ◽  
Abnormal Movements ◽  
Observational Cohort

Objective: Our study aims to estimate the incidence of non-convulsive status epilepticus (NCSE) in comatose children and to evaluate response to acute treatment with anticonvulsants. Material and methods: This is a prospective observational cohort study conducted in Pediatric Intensive Care Unit (PICU) of Ain-Shams University. Eighty patients presented with Glasgow coma scale (GCS) <8 and/or the presence of abnormal movements or vital sign fluctuations were enrolled in the study. All were subjected to EEG monitoring for at least 1 hour within 24 hours of presentation. Patients diagnosed as NCSE received anticonvulsant treatment and were reevaluated clinically and by EEG after 1 week. Results: Twenty four patients were diagnosed as NCSE (30%). EEG was normalized in 50% of patients after treatment. Conclusion: NCSE is possible to be under-recognized in the PICU settings because of the pleomorphic clinical features. Clinical suspension of NCSE and EEG monitoring for critically ill comatose children will improve their outcome

Dantrolene-Induced Hepatitis: A Rare Culprit in the PICU

2020 ◽  
Author(s):  
Divij Pasrija ◽  
Shilpi Gupta ◽  
Amanda Hassinger
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Case Report ◽  
Malignant Hyperthermia ◽  
Operating Room ◽  
Pediatric Intensive Care Unit ◽  
Side Effect ◽  
Hepatitis A ◽  
Pediatric Intensive Care ◽  
Anesthetic Agents

AbstractDantrolene is used for reversal of malignant hyperthermia and for improvement in spasticity following stroke which are Food and Drug Administration-approved indications. It is an infrequently used medication in the pediatric intensive care unit and is usually continued from the operating room or sedation suite after suspicion for malignant hyperthermia, secondary to other medications and anesthetic agents. Hepatitis has been described as a side effect of the medication after prolonged use and at doses of more than 100 mg/d mainly in adults. We described in this case report a patient in which the drug was used for sympathetic overactivity in the PICU and development of asymptomatic hepatitis on day 3 after starting the medication at a dose much lower than previously described.

Admissions to a pediatric intensive care unit for status epilepticus

1994 ◽  
Vol 22 (5) ◽  
pp. 827-832 ◽  
Author(s):  
JACQUES LACROIX ◽  
CHERI DEAL ◽  
MARIE GAUTHIER ◽  
ELIZABETH ROUSSEAU ◽  
CATHERINE ANN FARRELL
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Status Epilepticus ◽  
Pediatric Intensive Care Unit ◽  
Pediatric Intensive Care
Sign in / Sign up

Export Citation Format

Share Document